Funding for this research was provided by:
Instituto de Salud Carlos III (TRA007 and EC10-113)
Text and Data Mining valid from 2018-09-29
Received: 30 April 2018
Accepted: 6 September 2018
First Online: 29 September 2018
Ethics approval and consent to participate
: All patients provided informed consent approved as the clinical trial protocol by the CEIC of the local Government of Navarra (CEIC). The IMPD dossier and the clinical trial protocol were approved by Agencia Española del Medicamento y productos sanitarios (AEMPS). This was an investigator initiated clinical trial sponsored by UNAV and fulfills requirements by spanish law (<i>Real Decreto</i> 1090/2015).
: Informed consent included consent for publication and patients are coded and made anonym according to good clinical practices.
: IM served as an advisor to BMS, Roche, AstraZeneca, Genmab, Alligator, Tusk, Bioncotech, Merck-Serono.IM receives research grants from BMS, Roche and Alligator.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.